Purpose: Preoperative chemoradiotherapy (CRT) has been established as standard treatment for locally advanced rectal cancer after first results of the CAO/ARO/AIO-94 [Working Group of Surgical Oncology/Working Group of Radiation Oncology/Working Group of Medical Oncology of the Germany Cancer Society] trial, published in 2004, showed an improved local control rate. However, after a median follow-up of 46 months, no survival benefit could be shown VSports手机版. Here, we report long-term results with a median follow-up of 134 months. .

Patients and methods: A total of 823 patients with stage II to III rectal cancer were randomly assigned to preoperative CRT with fluorouracil (FU), total mesorectal excision surgery, and adjuvant FU chemotherapy, or the same schedule of CRT used postoperatively. The study was designed to have 80% power to detect a difference of 10% in 5-year overall survival as the primary end point V体育安卓版. Secondary end points included the cumulative incidence of local and distant relapses and disease-free survival. .

Results: Of 799 eligible patients, 404 were randomly assigned to preoperative and 395 to postoperative CRT. According to intention-to-treat analysis, overall survival at 10 years was 59. 6% in the preoperative arm and 59. 9% in the postoperative arm (P = . 85). The 10-year cumulative incidence of local relapse was 7. 1% and 10. 1% in the pre- and postoperative arms, respectively (P = . 048) V体育ios版. No significant differences were detected for 10-year cumulative incidence of distant metastases (29. 8% and 29. 6%; P = . 9) and disease-free survival. .

Conclusion: There is a persisting significant improvement of pre- versus postoperative CRT on local control; however, there was no effect on overall survival VSports最新版本. Integrating more effective systemic treatment into the multimodal therapy has been adopted in the CAO/ARO/AIO-04 trial to possibly reduce distant metastases and improve survival. .